Search Results 821-830 of 7758 for 不留痕搜索咨询邮箱:lgooxc@hotmail.com
About this study. The primary objective of this study is to evaluate the effect of selexipag on pulmonary vascular resistance (PVR) versus placebo in ...
Email: intl.mcr@mayo.edu. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions ...
Principal Investigator: Scott P. Steinman, M.D.. Project Coordinator: Mark E. Zobitz — zobitz.mark@mayo.edu. Shoulder Range of Motion and Strength in the High ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email ...
Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) ...
Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.
Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...
Email: opx@mayo.edu; Mail: Mayo Clinic Office of Patient Experience. 200 1st St. SW; Rochester, MN 55905. Share your story of gratitude to Mayo Clinic staff.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of cancer care.